BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38332637)

  • 21. Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting gastric cancer progression.
    Zhao H; Jiang R; Feng Z; Wang X; Zhang C
    J Transl Med; 2023 Nov; 21(1):833. PubMed ID: 37980488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated analysis of inflammatory response subtype-related signature to predict clinical outcomes, immune status and drug targets in lower-grade glioma.
    Cao Y; Zhu H; Chen Q; Huang H; Xie D; Li X; Jiang X; Ren C; Peng J
    Front Pharmacol; 2022; 13():914667. PubMed ID: 36091778
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification of an endoplasmic reticulum stress-related signature associated with clinical prognosis and immune therapy in glioma.
    Li L; Yang Z; Zheng Y; Chen Z; Yue X; Bian E; Zhao B
    BMC Neurol; 2022 May; 22(1):192. PubMed ID: 35614390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-1297 sensitizes glioma cells to temozolomide (TMZ) treatment through targeting adrenomedullin (ADM).
    He Z; Cheng M; Hu J; Liu L; Liu P; Chen L; Cao D; Tang J
    J Transl Med; 2022 Oct; 20(1):443. PubMed ID: 36183123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signature Construction and Disulfidptosis-Related Molecular Cluster Identification for Better Prediction of Prognosis in Glioma.
    Zhuang Y; Chen J; Mai Z; Huang W; Zhong W
    J Mol Neurosci; 2024 Apr; 74(2):38. PubMed ID: 38573391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimized risk stratification strategy for glioma patients based on the feature genes of poor immune cell infiltration patterns.
    Wan HT; Su ZJ; Guo ZS; Wen P; Hong XY
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):13855-13874. PubMed ID: 37535161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of cuproptosis molecular subtype-related signature for predicting immune prognostic characterization in gliomas.
    Huang H; Lv Z; Yang L; Zhang X; Deng Y; Huang Z; Bi H; Sun X; Zhang M; Hu D; Liang H; Hu F
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11499-11515. PubMed ID: 37392200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenomedullin induces cisplatin chemoresistance in ovarian cancer through reprogramming of glucose metabolism.
    Dou L; Lu E; Tian D; Li F; Deng L; Zhang Y
    J Transl Int Med; 2023 Jul; 11(2):169-177. PubMed ID: 37408575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma.
    Li J; Guo Q; Xing R
    BMC Cancer; 2023 Aug; 23(1):727. PubMed ID: 37543576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purine metabolism-related gene expression signature predicts survival outcome and indicates immune microenvironment profile of gliomas.
    Chen S; Zhang S; Wang Z; Li J; Yuan Y; Li T; Zuo M; Feng W; Li W; Chen M; Liu Y
    Front Pharmacol; 2022; 13():1038272. PubMed ID: 36438805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Machine learning-based investigation of regulated cell death for predicting prognosis and immunotherapy response in glioma patients.
    Zhang W; Dang R; Liu H; Dai L; Liu H; Adegboro AA; Zhang Y; Li W; Peng K; Hong J; Li X
    Sci Rep; 2024 Feb; 14(1):4173. PubMed ID: 38378721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and Validation of the Glycolysis and Immune-related Gene Signature for Prognosis in Colorectal Cancer.
    Jiang M; Liu Y; Xu J; Xu Z; Ye T; Li S; Jiang C
    Anticancer Res; 2024 Jan; 44(1):117-131. PubMed ID: 38159970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Grade scoring system reveals distinct molecular subtypes and identifies KIF20A as a novel biomarker for predicting temozolomide treatment efficiency in gliomas.
    Ye L; Tong S; Wang Y; Wang Y; Ma W
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):9857-9876. PubMed ID: 37248320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Ferroptosis-Related Gene Prognostic Index to Predict Temozolomide Sensitivity and Immune Checkpoint Inhibitor Response for Glioma.
    Cai Y; Liang X; Zhan Z; Zeng Y; Lin J; Xu A; Xue S; Xu W; Chai P; Mao Y; Song Z; Han L; Xiao J; Song Y; Zhang X
    Front Cell Dev Biol; 2021; 9():812422. PubMed ID: 35174170
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification of an energy metabolism-related signature associated with clinical prognosis in diffuse glioma.
    Zhou Z; Huang R; Chai R; Zhou X; Hu Z; Wang W; Chen B; Deng L; Liu Y; Wu F
    Aging (Albany NY); 2018 Nov; 10(11):3185-3209. PubMed ID: 30407923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneity in clinical prognosis, immune infiltration and molecular characteristics of three glycolytic subtypes in lower-grade gliomas.
    Wu S; Sheng L; Fan S; Guo X; Zhu B; Wu C; Lei B
    Front Oncol; 2023; 13():1180662. PubMed ID: 37274274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear mitochondria-related genes-based molecular classification and prognostic signature reveal immune landscape, somatic mutation, and prognosis for glioma.
    Liu C; Zhang N; Xu Z; Wang X; Yang Y; Bu J; Cao H; Xiao J; Xie Y
    Heliyon; 2023 Sep; 9(9):e19856. PubMed ID: 37809472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive analysis of pyroptosis regulation patterns and their influence on tumor immune microenvironment and patient prognosis in glioma.
    Fan T; Wan Y; Niu D; Wang B; Zhang B; Zhang Z; Zhang Y; Gong Z; Zhang L
    Discov Oncol; 2022 Mar; 13(1):13. PubMed ID: 35274175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma.
    Zeng Y; Cai Y; Chai P; Mao Y; Chen Y; Wang L; Zeng K; Zhan Z; Xie Y; Li C; Zhan H; Zhao L; Chen X; Zhu X; Liu Y; Chen M; Song Y; Zhou A
    Front Immunol; 2022; 13():961933. PubMed ID: 35990696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel prognostic features and personalized treatment strategies for mitochondria-related genes in glioma patients.
    Wu J; Zhou J; Chai Y; Qin C; Cai Y; Xu D; Lei Y; Mei Z; Li M; Shen L; Fang G; Yang Z; Cai S; Xiong N
    Front Endocrinol (Lausanne); 2023; 14():1172182. PubMed ID: 37091853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.